AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. INO
  4. [SCHEDULE 13G/A] Inovio Pharmaceuticals, Inc. SEC Filing

[SCHEDULE 13G/A] Inovio Pharmaceuticals, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Filing content is currently unavailable.

Source:

Stock INO logo
Inovio Pharmaceu

NASDAQ:INO

INO Rankings

#4703 Ranked by Market Cap
N/A Ranked by Dividends

INO Latest News

Aug 26, 2025
INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults
Aug 25, 2025
INOVIO to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Aug 12, 2025
INOVIO Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Aug 11, 2025
Data Published in The Laryngoscope shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)
Aug 4, 2025
INOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025

INO Latest SEC Filings

Aug 12, 2025
[8-K] Inovio Pharmaceuticals, Inc. Reports Material Event
Aug 12, 2025
[10-Q] Inovio Pharmaceuticals, Inc. Quarterly Earnings Report
Jul 7, 2025
[8-K] Inovio Pharmaceuticals, Inc. Reports Material Event
Jul 3, 2025
[424B5] Inovio Pharmaceuticals, Inc. Prospectus Supplement (Debt Securities)
Jul 2, 2025
[424B5] Inovio Pharmaceuticals, Inc. Prospectus Supplement (Debt Securities)

INO Stock Data

104.16M
52.86M
0.51%
19.04%
10%
Biotechnology
Pharmaceutical Preparations
United States
PLYMOUTH MEETING